Global ETD Search

1	Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy / シスプラチン5日間分割連日投与を含む化学療法を施行中の精巣腫瘍患者を対象としたパロノセトロン、アプレピタント及びデキサメタゾン併用制吐療法の有効性及び安全性評価に関する研究 Hamada, Shota 24 September 2014 (has links) Published in Supportive Care in Cancer 2014;22(8):2161-6. DOI:10.1007/s00520-014-2182-7 / 京都大学 / 0048 / 新制・課程博士 / 博士(社会健康医学) / 甲第18548号 / 社医博第59号 / 新制\|\|社医\|\|8(附属図書館) / 31448 / 京都大学大学院医学研究科社会健康医学系専攻 / (主査)教授武藤学, 教授佐藤俊哉, 教授千葉勉 / 学位規則第4条第1項該当 / Doctor of Public Health / Kyoto University / DFAM chemotherapy-induced nausea and vomiting emesis multiple-day chemotherapy multiple-cycle antiemetic 493
2	Charakterisierung des 5-HT<sub>3B</sub>-Promotors der Ratte vor dem Hintergrund eines mit Chemotherapie-induziertem Erbrechen assoziierten Polymorphismus / Characterization of the rat 5-HT<sub>3B</sub> promoter on the basis of a polymorphism associated with chemotherapy-induced vomiting Bokelmann, Kristin 19 July 2011 (has links) No description available. 570 Biowissenschaften, Biologie Biology (incl. Psychology) 5-HT<sub>3B</sub> HTR<sub>3B</sub> Serotoninrezeptor Typ 3 Promotor -100_-102delAAG-Polymorphismus Transkription TATA-frei 5-HT<sub>3B</sub> HTR<sub>3B</sub> serotonin receptor type 3 promoter -100_-102delAAG polymorphism transcription TATA-less 42.13 44.81 44.38 MED 353: Pharmakotherapie

Search results

Charakterisierung des 5-HT<sub>3B</sub>-Promotors der Ratte vor dem Hintergrund eines mit Chemotherapie-induziertem Erbrechen assoziierten Polymorphismus / Characterization of the rat 5-HT<sub>3B</sub> promoter on the basis of a polymorphism associated with chemotherapy-induced vomiting